[go: up one dir, main page]

DE69001487D1 - Gemfibrozil enthaltende mittel mit verlaengerter freigabe. - Google Patents

Gemfibrozil enthaltende mittel mit verlaengerter freigabe.

Info

Publication number
DE69001487D1
DE69001487D1 DE9090102021T DE69001487T DE69001487D1 DE 69001487 D1 DE69001487 D1 DE 69001487D1 DE 9090102021 T DE9090102021 T DE 9090102021T DE 69001487 T DE69001487 T DE 69001487T DE 69001487 D1 DE69001487 D1 DE 69001487D1
Authority
DE
Germany
Prior art keywords
gemfibrozil
extended release
agents containing
granulation
disintegratable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE9090102021T
Other languages
English (en)
Other versions
DE69001487T2 (de
Inventor
Isaac Ghebre-Sellassie
Mahdi Fawzi
Uma Iyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of DE69001487D1 publication Critical patent/DE69001487D1/de
Application granted granted Critical
Publication of DE69001487T2 publication Critical patent/DE69001487T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE9090102021T 1989-02-02 1990-02-01 Gemfibrozil enthaltende mittel mit verlaengerter freigabe. Expired - Fee Related DE69001487T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/305,083 US4925676A (en) 1989-02-02 1989-02-02 Extended release gemfibrozil composition

Publications (2)

Publication Number Publication Date
DE69001487D1 true DE69001487D1 (de) 1993-06-09
DE69001487T2 DE69001487T2 (de) 1993-08-26

Family

ID=23179257

Family Applications (1)

Application Number Title Priority Date Filing Date
DE9090102021T Expired - Fee Related DE69001487T2 (de) 1989-02-02 1990-02-01 Gemfibrozil enthaltende mittel mit verlaengerter freigabe.

Country Status (20)

Country Link
US (1) US4925676A (de)
EP (1) EP0381218B1 (de)
JP (1) JPH02235810A (de)
CN (1) CN1044590A (de)
AT (1) ATE88888T1 (de)
AU (1) AU624217B2 (de)
CA (1) CA2009134A1 (de)
DE (1) DE69001487T2 (de)
DK (1) DK0381218T3 (de)
ES (1) ES2055176T3 (de)
FI (1) FI900492A0 (de)
HU (1) HU204194B (de)
IE (1) IE900372L (de)
IL (1) IL92995A0 (de)
MY (1) MY104899A (de)
NO (1) NO900483L (de)
NZ (1) NZ232322A (de)
PH (1) PH26308A (de)
PT (1) PT93028A (de)
ZA (1) ZA90778B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
EP0462067A1 (de) * 1990-06-15 1991-12-18 Warner-Lambert Company Gemfibrozil-Formulierung
EP0462066A1 (de) * 1990-06-15 1991-12-18 Warner-Lambert Company Amorphes Gemfibrozil
EP0475894A1 (de) * 1990-08-27 1992-03-18 Warner-Lambert Company Verbesserte Gemfibrozil-Formulierungen
US5102668A (en) * 1990-10-05 1992-04-07 Kingaform Technology, Inc. Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
US5492700A (en) * 1991-11-26 1996-02-20 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
EP0614358A1 (de) * 1991-11-26 1994-09-14 Warner-Lambert Company Verfahren und zusammensetzung für die entwicklung einer gemfibrozil dosierungsform mit kontrollierter freigabe
US5358723A (en) * 1991-11-26 1994-10-25 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
HU212428B (en) * 1994-05-13 1996-06-28 Egyt Gyogyszervegyeszeti Gyar Process to prepare pharmaceutical compositions containing gemfibrozyl
US7014864B1 (en) 1998-12-18 2006-03-21 Abbott Laboratories Formulations comprising lipid-regulating agents
US6814977B1 (en) 1998-12-18 2004-11-09 Abbott Laboratories Formulations comprising lipid-regulating agents
US6838091B2 (en) * 1998-12-18 2005-01-04 Abbott Laboratories Formulations comprising lipid-regulating agents
US6719999B2 (en) 1999-03-31 2004-04-13 Abbott Laboratories Formulations comprising lipid-regulating agents
US6372251B2 (en) 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
ATE359777T1 (de) * 2002-12-17 2007-05-15 Abbott Gmbh & Co Kg Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
PL1753398T3 (pl) * 2004-06-10 2019-04-30 Glatt Air Techniques Inc Macierz o kontrolowanym uwalnianiu farmaceutycznej formulacji dawkowania

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
US4291016A (en) * 1976-07-27 1981-09-22 Sandoz Ltd. Enteric coated mixture of 4-(2-hydroxy-3-isopropylamino-propoxy) indole and sodium lauryl sulphate
US4195084A (en) * 1977-01-07 1980-03-25 Eli Lilly And Company Taste-stable aqueous pharmaceutical suspension of tall oil sitosterols and a method for the preparation thereof
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
HU190619B (en) * 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
JPS618A (ja) * 1984-06-09 1986-01-06 Sawai Seiyaku Kk ニフエジピン含有製剤
JPS6144811A (ja) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd 徐放性ジクロフエナクナトリウム製剤
DE3678644D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Wirkstoffpartikel mit sowohl kontinuierlicher als auch schneller freisetzung.
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives
IL81419A0 (en) * 1986-01-30 1987-08-31 Syntex Inc Long acting sustained release pharmaceutical compositions containing dihydropyridines and their preparation
US4716033A (en) * 1986-03-27 1987-12-29 Warner-Lambert Company Medicament adsorbates with surfactant and their preparation
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
WO1988005296A2 (en) * 1987-01-27 1988-07-28 Warner-Lambert Company Lpid regulating compositions

Also Published As

Publication number Publication date
NO900483D0 (no) 1990-02-01
US4925676A (en) 1990-05-15
EP0381218A3 (en) 1990-12-05
NZ232322A (en) 1991-02-26
HUT52952A (en) 1990-09-28
ATE88888T1 (de) 1993-05-15
CN1044590A (zh) 1990-08-15
ES2055176T3 (es) 1994-08-16
ZA90778B (en) 1991-10-30
CA2009134A1 (en) 1990-08-02
EP0381218B1 (de) 1993-05-05
MY104899A (en) 1994-06-30
EP0381218A2 (de) 1990-08-08
IL92995A0 (en) 1990-09-17
PH26308A (en) 1992-04-29
IE900372L (en) 1990-08-02
AU624217B2 (en) 1992-06-04
AU4899090A (en) 1990-08-09
HU900640D0 (en) 1990-04-28
DK0381218T3 (da) 1993-06-01
HU204194B (en) 1991-12-30
DE69001487T2 (de) 1993-08-26
JPH02235810A (ja) 1990-09-18
PT93028A (pt) 1990-08-31
NO900483L (no) 1990-08-03
FI900492A0 (fi) 1990-01-31

Similar Documents

Publication Publication Date Title
ATE88888T1 (de) Gemfibrozil enthaltende mittel mit verlaengerter freigabe.
FR2685869B1 (fr) Compositions therapeutiques a base d'inhibiteurs mixtes de la no synthase et de la cyclooxygenase.
NO902703L (no) Nye o-(3-amino-2-hydroxypropyl)-hydroximinsyrehalogeniderog fremgangsmaate for fremstilling av disse.
IT8225032A0 (it) Dispersioni polimere di poliurea-poliuretano acrilato erelativo procedimento di preparazione.
DK180389A (da) Fremgangsmaade til desinfektion af lokaler samt anlaeg til udoevelse af fremgangsmaaden
NO883416D0 (no) Innretning for dynamisk tverrfeste av foten.
ATE122880T1 (de) Mehrfach teilbare tablettenstruktur.
IT8921898A0 (it) Procedimento e dispositivo per l'applicazione di fascette su confezioni.
FI850126L (fi) Foerfarande foer framstaellning av vattenloesliga polymerer.
FR2624012B1 (fr) Nouvelles compositions pharmaceutiques a action hypnotique a base d'hydrate de chloral
NO884018L (no) Fremgangsmaate for fremstilling av en friradikal-addisjonspolymer.
ATE89720T1 (de) Wasserdisperierbare gemfibrozilhaltige mittel.
FR2589358B1 (fr) Compositions pharmaceutiques a base de diltiazem et d'aspirine
BE856849A (fr) Composition pharmaceutique a base d'organophosphate et de sulfoxyde
AU5284286A (en) Antiinflammatory composition of inositol and piroxicam
FR2714603B1 (fr) Composition dermatologique et son utilisation pour la préparation d'un médicament.
DE3861938D1 (de) Kombinierte kupplungs- und bremsvorrichtung.
NO893326L (no) Fremgangsmaate for noeytralisering av svovelsyre inneholdende sinkioner.
NZ217489A (en) Pharmaceutical composition of ace inhibitor and a loop diuretic and the combination product of these two agents
NO905063L (no) Fremgangsmaate for fremstilling samt anvendelse av pyridin-2-4- og 2,5- dikarboksylsyrediamider.
KR890019108U (ko) 클러치 겸용 가속 페달
NO903838D0 (no) Fremgangsmaate for fremstilling av tamponger samt tampong fremstilt derved.
KR890010851U (ko) 조속기의 부분 부하시 앵글라이히 감소장치
IT1223097B (it) Formulazione farmaceutica contenente gemfibrozil microincapsulato
ATE97793T1 (de) Zahntechnisch-prothetisches angussverfahren und primaerteil hierfuer.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee